DV
Dividend Vision

BFRI — Biofrontera Inc

Biofrontera Inc (BFRI)

Total return is -98.5% over the past 4.8 years, 178.8 points behind SPY at 80.3%. Its deepest 1-year drawdown was 50.9%.

BFRI is a single-stock equity fund focused on Biofrontera Inc, a specialty pharmaceutical company, rather than a diversified ETF portfolio. The fund does not currently pay distributions and lacks disclosed expense ratio and asset under management figures. This structure appeals primarily to investors seeking direct exposure to Biofrontera's business performance, though it lacks the diversification and income characteristics typical of dividend-focused ETF strategies.

BFRI key facts

Asset type
Stock
Asset class
Equity
Inception date
10/29/2021
Last close
$1.30
Market cap
$13,955,645
Average volume
973000.0
Beta
0.825
Payout ratio
0.0
Forward P/E
13.6426
EPS
$-0.98